<DOC>
	<DOCNO>NCT00853879</DOCNO>
	<brief_summary>This study conduct assess impact folate L-methylfolate progression Parkinson 's . The investigator specifically look effect nutritional supplement Parkinson 's patient antibody effect body 's utilization folate . An antibody protein produce body 's immune system recognize foreign substance . Normally , people antibody prevents folate work properly brain appear people may antibody . Folate important vitamin take part many critical cell function antibody prevent enter brain properly could cause worsen certain neurological disorder like Parkinson 's . The result preliminary study help determine whether reasonable proceed study supplement treatment Parkinson 's . Patients interested participate blood test see folate antibody . Patients antibody eligible participate study . The investigator measure effect folate L-methylfolate Parkinson 's disease measuring change Parkinson 's disease symptom three month treatment . The investigator also look blood individual Parkinson 's . This call control group allow u compare common folate antibody general population compare Parkinson 's population .</brief_summary>
	<brief_title>An Exploratory , Randomized , Blinded , Placebo-Controlled Trial Folic Acid L-methylfolate Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Tetrahydrofolates</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>PD subject : Diagnosis Parkinson 's base upon presence 2 cardinal clinical feature disease determined movement disorder specialist . Age &gt; 30 . Able provide inform consent . All antiParkinson 's medication permit evaluation do medication OFF state ( least 12 hour follow last dose medication ) . Healthy Controls *Age &gt; 30 PD Subjects : Age &lt; 30 . Presence concomitant active neurological disorder deem significant investigator . History clinically significant diabetes , vascular disease , renal , thyroid hepatic dysfunction Leber 's optic neuropathy determine investigator . History significant medical illness determine investigator . The following medication exclude : thiazide diuretic , azathioprine , phenytoin , phenobarbital , primidone , sulfacontaining medication , cimetidine , antituberculosis medication , methotrexate , chemotherapeutic agent oral contraceptive . Subjects take vitamin supplementation excess one daily standard multivitamin . Pregnancy ( exclude perceive risk pregnant woman take supplemental folate ) . Healthy Controls : Age &lt; 30 Any known active neurological condition deem significant investigator . History significant , active renal hepatic dysfunction determine investigator . History significant active medical illness determine investigator . The following medication exclude : thiazide diuretic , azathioprine , phenytoin , phenobarbital , primidone , sulfacontaining medication , cimetidine , antituberculosis medication , methotrexate , chemotherapeutic agent oral contraceptive . Subjects take vitamin supplementation excess one standard daily multivitamin . Pregnancy ( pregnant woman take folate ) .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>